• Carbon

    38 Thousand (Tonnes)
  • Waste

    12 Thousand (Tonnes)
  • Water

    373.51 Thousand (Cubic Meters)
  • Energy

    451 Thousand (Gigajoules)
  • Revenue

    2,625 Million USD
Rank 19
Rank 23
Rank
LUN-KO
DK0010287234
DENMARK
Health Care
Pharmaceuticals

About Company

H. Lundbeck A/S (CPH:LUN) is a Denmark-based company active within the specialty pharmaceuticals industry. The Company is engaged in the research, development, manufacturing and marketing of pharmaceuticals for the treatment of diseases of the central nervous system (CNS).

H. Lundbeck A/S operates through global subsidiaries. Its production units are located in Denmark, Italy and Mexico, and research facilities in Denmark and the United States. The Company's main areas of focus comprise Alzheimer's disease, depression and mood disorders, alcohol dependence, Parkinson's disease, primary insomnia, schizophrenia and psychotic disorders, as well as acute ischemic stroke. Its main products include Azilect, for the treatment of Parkinson's disease; Cipralex/Lexapro, for the treatment of depression and anxiety; Circadin, for the treatment of primary insomnia; Ebixa, for the treatment of moderate to severe Alzheimer's disease, and Serdolect for the treatment of schizophrenia

Lundbeck is listed on the Copenhagen Stock Exchange (CSE) and a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)

Company Website: www.lundbeck.com
Corporate Responsibility Website: Corporate Responsibility at Lundeck

Top Competitors of
H Lundbeck A/S

  • Novo Nordisk A/S

    ESG Rank 10
    Novo Nordisk A/S (OMX: NOVO B, NYSE: NVO) is a Denmark-based health care company engaged in the discovery, development, manufacturing and marketi..
    Read more...

Subscribe to the
Justmeans ESG Dashboard

A subscription includes full access to Environmental, Social, and Governance Data, company comparisons, ability to share data charts, custom reports, and more.

Learn more...